跳至主要内容
临床试验/NCT05994586
NCT05994586招募中不适用

The Effect of Mix AP029 on the Efficacy of Metformin Therapy and Its Side Effects in Patients With Type II Diabetes and on Mechanisms Related to Prediabetes in Patients With Impaired Carbohydrate-lipid Metabolism

AronPharma Sp. z o. o.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年5月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Glucose level

研究概览

简要总结

The aim of the study is to demonstrate that a daily supplementation of AP029 Mix: I) has a positive effect on reducing side effects of metformin, while enhancing the therapeutic effect of metformin; II) normalizes prediabetes biomarkers in order to prevent further progression into diabetes.

详细描述

Randomized, double-blind, cross over study conducted under medical supervision on 1) group of 20 patients with type II diabetes and 2) group of 10 patients with prediabetes.

Study design: 2 months of AP029 supplementation, 1 month wash-out, 2 months of placebo intake. Patients will attend 4 visits. On each visit, the following parameters are analyzed: level of glucose, insulin, HbA1c, hsCRP lipid panel (total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL), HDL) and inflammatory and oxidative stress markers. In addition, a questionnaire of symptoms associated with metformin intake will be conducted

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •for type II diabetes:
  • •Women and men, 18-75 years old
  • •Patients diagnosed with type II diabetes mellitus
  • •Patients on metformin treatment up to 5 months
  • •BMI 20-35 kg/m2
  • •Signed informed consent
  • •Inclusion Criteria for prediabetes:
  • •Women and men, 18-75 years old
  • •BMI 20-35 kg/m2
  • •Fasting blood glucose levels between 100 mg/dl and 125 mg/dl (5.6-6.9 mmol/l)
  • •Signed informed consent

排除标准

  • •for type II diabetes:
  • •Patients diagnosed with type I diabetes
  • •Patients receiving insulin or other anti-diabetic medications
  • •Women who are pregnant, planning to become pregnant during the study, or breastfeeding
  • •Surgery within the last 6 months
  • •Intake of dietary supplements containing plant extracts rich in polyphenols and anthocyanins
  • •Intake of supplements containing: white mulberry, chromium, berberine
  • •Patients receiving glucocorticosteroids, immunosuppressants
  • •Oncological disease, autoimmune disease, severe liver dysfunction, tuberculosis, leukemia, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplant
  • •Acute inflammation (C-reactive protein >20mg/dl)
  • •Exclusion Criteria for prediabetes:
  • •Patients diagnosed with type I, II, LADA diabetes
  • •Patients receiving insulin or other anti-diabetic medications
  • •Women who are pregnant, planning to become pregnant during the study, or breastfeeding
  • •Surgery within the last 6 months
  • •Intake of dietary supplements containing plant extracts rich in polyphenols and anthocyanins
  • •Intake of supplements containing: white mulberry, chromium, berberine
  • •Patients receiving glucocorticosteroids, immunosuppressants
  • •Oncological disease, autoimmune disease, severe liver dysfunction, tuberculosis, leukemia, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplant
  • •Acute inflammation (C-reactive protein >20mg/dl)

研究组 & 干预措施

AP029 mix - type II diabetes

Experimental

Patients with type II diabetes receiving metformin for up to 5 months

干预措施: AP029 mix (Dietary Supplement)

AP029 mix - prediabetes

Experimental

Patients with pre-diabetic

干预措施: AP029 mix (Dietary Supplement)

Placebo - type II diabetes

Placebo Comparator

Patients with type II diabetes receiving metformin for up to 5 months

干预措施: Placebo (Other)

Placebo - prediabetes

Placebo Comparator

Patients with pre-diabetic

干预措施: Placebo (Other)

结局指标

主要结局

Glucose level

时间窗: Baseline, 2 months, 3 months, 5 months

Comparison of glucose level

Discomfort related to metformin side effects

时间窗: Baseline, 2 months, 3 months, 5 months

Based on questionnaire

Insulin level

时间窗: Baseline, 2 months, 3 months, 5 months

Comparison of insulin level

次要结局

  • HbA1c level(Baseline, 2 months, 3 months, 5 months)
  • hsCRP level(Baseline, 2 months, 3 months, 5 months)
  • Lipid panel (total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), HDL)(Baseline, 2 months, 3 months, 5 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验